Free shipping on all orders over $ 500

Sotrastaurin

Cat. No. M3803

All AbMole products are for research use only, cannot be used for human consumption.

Sotrastaurin Structure
Synonym:

AEB071

Size Price Availability Quantity
2mg USD 55 In stock
5mg USD 105 In stock
10mg USD 175 In stock
50mg USD 620 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Sotrastaurin is a potent and specific inhibitor of protein kinase C (PKC) with Ki at subnanomolar to low nanomolar range for a variety of PKC isotypes while selective for >200 other kinases. Sotrastaurin is an immunosuppressant that blocks early T-lymphocyte (T-cell) activation via protein kinase C inhibition. Sotrastaurin combined with EVR showed higher efficacy failure rates and some improvement in renal allograft function compared to a CsA-based therapy. Sotrastaurin inhibits nuclear factor (NF)-κB, which directly promotes the transcription of forkhead box protein 3 (FoxP3), the key regulator for the development and function of regulatory T cells (Tregs). Sotrastaurin is a potent inhibitor of alloreactivity in vitro, while it did not affect Treg function in patients after kidney transplantation. Sotrastaurin prevented TCR/CD28-induced T-cell activation and pro-inflammatory cytokine production, but preserved a stable Treg phenotype as evidenced by maintenance of suppressive capacity, high Foxp3 and CD25 expression, and lack of IL-17A and IFNγ production.

Protocol (for reference only)
Cell Experiment
Cell lines
Preparation method
Concentrations
Incubation time
Animal Experiment
Animal models male Wistar/F rats
Formulation Saline
Dosages 10 mg/kg and 30 mg/kg
Administration Orally administrated
Chemical Information
Molecular Weight 438.48
Formula C25H22N6O2
CAS Number 425637-18-9
Solubility (25°C) DMSO 50 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] He X, et al. J Invest Dermatol. Targeting PKC in human T cells using sotrastaurin (AEB071) preserves regulatory T cells and prevents IL-17 production.

[2] de Weerd A, et al. Clin Exp Immunol. The protein kinase C inhibitor sotrastaurin allows regulatory T cell function.

[3] Russ GR, et al. Am J Transplant. Efficacy of sotrastaurin plus tacrolimus after de novo kidney transplantation: randomized, phase II trial results.

[4] Tedesco-Silva H, et al. Am J Transplant. Sotrastaurin in calcineurin inhibitor-free regimen using everolimus in de novo kidney transplant recipients.

[5] Manicassamy S. Curr Opin Investig Drugs. Sotrastaurin, a protein kinase C inhibitor for the prevention of transplant rejection and treatment of psoriasis.

Related PKC Products
Enzastaurin

Enzastaurin inhibits PKCβ, PKCα, PKCγ and PKCε with IC50's of 0.006, 0.039, 0.083 and 0.110 µM, respectively.

Go 6983

Go 6983 is a fast acting, lipid soluble, broad spectrum protein kinase C inhibitor.

Staurosporine

Staurosporine (AM-2282) is a potent ATP-competitive kinase inhibitor with IC50 of 0.7, 7, 8.5, 6, 20 nM for PKC, PKA,PKG, p60v-src tyrosine protein kinase, CaM kinase II, respectively.

Zoledronic acid

Zoledronic Acid (Zoledronate) is a third-generation bisphosphonate (BP), with potent anti-resorptive activity. Zoledronic Acid inhibits the differentiation and apoptosis of osteoclasts. Zoledronic Acid also has anti-cancer effects.

Dequalinium Chloride

Dequalinium Chloride is a PKC inhibitor with IC50 of 7-18 μM, and also a selective blocker of apamin-sensitive K+ channels with IC50 of 1.1 μM.

  Catalog
Abmole Inhibitor Catalog




Keywords: Sotrastaurin, AEB071 supplier, PKC, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.